Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake

A method for treating an impulse control disorder in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound selected from ibogaine, an ibogaine derivative, and a pharmaceutically acceptable salt and/or solvate thereof, the ibogaine derivative selected from the group consisting of coronaridine, voacangine, 18-methoxycoronaridine, 2-methoxyethyl-18-methoxycoronaridinate, and 18-methylaminocoronaridine:

• wherein the patient is not addicted to cocaine or an opiate, and further wherein the therapeutically effective amount provides an efficacious average serum level of ibogaine or the ibogaine derivative of less than about 180 ng/mL while maintaining a QT interval of less than about 500 ms during said treatment.